The "Test Before Treat" campaign is specifically aimed at the approximately 50% of CLL and SLL patients who have high-risk molecular features that can impact the efficacy of some treatments, per ...
About 50% of patients with CLL/SLL have high-risk molecular features limiting effectiveness of certain treatments; a blood test can identify these features and help guide which therapy is most likely ...
IGHV status significantly influences CLL prognosis, with mutated IGHV linked to longer survival and unmutated IGHV to shorter progression-free survival. NGS enhances IGHV analysis by overcoming Sanger ...
Whole-genome testing uncovered hidden cancer predisposition in children with leukemia, changing treatment and surveillance in ...
Patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHLs) who received frequent tests for immunoglobulin G (IgG) were less likely to experience severe infections compared with ...
Patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHLs) who received frequent tests for immunoglobulin G (IgG) were less likely to experience severe infections compared with ...
Chronic lymphocytic leukemia (CLL), the most common leukemia of adults in Western countries, is standing at a genuine ...
Dr. Lipsky outlines MRD testing utility across the three major treatment approaches. Dr. Lipsky outlines MRD testing utility across the three major treatment approaches. For continuous BTKi ...
A key question you’ll likely have after chronic lymphocytic leukemia (CLL) treatment is how well it worked. At that point, your care team may mention “remission,” which means there’s no sign of cancer ...
Chromosome testing and genetic testing.It seems that even for the same "acute myeloid leukemia," subsequent treatment plans and the like change depending on the characteristics of the chromosomes and ...
The Test Before Treat campaign highlights how a patient’s genetic profile can change over time and encourages the use of a blood test to identify mutations to provide important insights into disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results